Session Details

F039 Botulinum Toxins: The Latest Updates

Sat, Mar 8, 1:00 PM - 3:00 PM
Valencia Ballroom A
2 CME Available Forum
View Map

DESCRIPTION

Open admission to eligible categories, no tuition or ticket

Botulinum Toxin use has advanced significantly since its introduction in aesthetics. There are currently multiple choices of BNTA products and evolving indications and uses. This forum aims to examine where we came from and what is new in understanding our clinical use of neuromodulators. We will present data on the similarities and differences in those drugs both available and soon to be available, as well as new injection techniques and potential indications. Reconstitution variations and psychosocial impacts on patients will also be highlighted.

LEARNING OBJECTIVES

1.

Discriminate between the various neuromodulators on the market

2.

Determine ideal injection locations and anatomic safety zones to obtain the maximum efficacy

3.

Appreciate the objective and subjective outcomes of neuromodulator treatments on patients

SCHEDULE

6:00 PM

Intorduction

Joely Kaufman, MD, FAAD

6:05 PM

Whats old and whats new

Jean D.A. Carruthers, MD

6:20 PM

Dose & Reconstitution: Best Recommendations

John Joseph

6:36 PM

Anatomy of Injections

Andre Vieira Braz, MD

6:52 PM

Botulinum Toxin for the Neck: Beyond the Platysma

Doris M Hexsel, MD, IFAAD

7:08 PM

Liquid Toxins: What Advantages can we expect?

Joely Kaufman, MD, FAAD

7:24 PM

Physosocial implications of Neuromodulator injections

Vince Bertucci, MD, FAAD

7:40 PM

Q & A with Faculty

SPEAKERS

Vince Bertucci, MD, FAAD

Vince Bertucci, MD, FAAD

Andre Vieira Braz, MD

Andre Vieira Braz, MD

Jean D.A. Carruthers, MD

Jean D.A. Carruthers, MD

Doris M Hexsel, MD, IFAAD

Doris M Hexsel, MD, IFAAD

John Joseph

John Joseph

Joely Kaufman, MD, FAAD

Joely Kaufman, MD, FAAD

SPEAKER DISCLOSURES

Vince Bertucci, MD, FAAD

Allergan, Inc – Consultant (1099 relationship)(Fees); Allergan, Inc. – Advisory Board(Fees), Investigator(Fees), Speaker(Honoraria); AMNI Aesthetic Medicine Network Inc. – Consultant(Honoraria), Stockholder Private Company(Stock); Caliway Biopharmaceuticals Co., Ltd – Investigator(Fees); Clarion Medical Technologies – Speaker(Honoraria); Evolus, Inc. – Speaker(Honoraria); Galderma Canada, Inc – Speaker(Honoraria); Galderma Laboratories, L.P. – Advisory Board(Fees); Galderma USA – Investigator(Fees); L'Oreal – Advisory Board(Fees), Consultant (1099 relationship)(Fees); Medscape – Speaker/Faculty Education(Fees); Revance Therapeutics, Inc. – Advisory Board(Fees); TEOXANE Laboratories – Speaker(Fees);

Andre Vieira Braz, MD

Allergan, Inc – Speaker(Honoraria);

Jean D.A. Carruthers, MD

Alastin Skincare, Inc – Consultant(Grants/Research Funding); Allergan, Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Alphaeon – Investigator(Grants/Research Funding); Bonti – Consultant(No Compensation Received); Fount Bio – Consultant (1099 relationship)(No Compensation Received); Kythera – Consultant(Honoraria); Merz Aesthetics – Consultant(Honoraria), Investigator(Honoraria); Revance Therapeutics, Inc. – Investigator(Honoraria); Sofwave – Consultant (1099 relationship)(Fees);

Doris M Hexsel, MD, IFAAD

No financial relationships exist with ineligible companies.

John Joseph

Allergan – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Croma-Pharma GmbH Austria – Investigator(Grants/Research Funding); Evolus, Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Galderma – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Jetema – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Merz Aesthetics – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Revance Therapeutics, Inc. – Advisory Board(Honoraria); Sinclair Pharma – Advisory Board(Honoraria);

Joely Kaufman, MD, FAAD

Allergan, Inc – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Alphaeon – Stockholder(No Compensation Received); Galderma USA – Advisory Board(Honoraria), Investigator(Fees); Jetema – Investigator(Grants/Research Funding); Johnson and Johnson – Investigator(Grants/Research Funding); L'Oreal – Investigator(Grants/Research Funding); Merz Pharmaceuticals, LLC – Investigator(Grants/Research Funding); Neutrogena Corporation – Advisory Board(Honoraria); OneSkin – Consultant (1099 relationship)(Honoraria); Revance Therapeutics, Inc. – Investigator(Fees); Silk Medical Aesthetics Inc. – Investigator(Grants/Research Funding); TEOXANE Laboratories – Investigator(Fees);